Company · CIK 0001997296 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Medicus Pharma Ltd. · MDCX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2026 AForm 4 → | Sep 8, 5:02 pm EDT | Andrew Alasdair SmithChief Operating Officer | 735,294 | $0.1705 | $125,368 | 735,458 | — | |
| Sep 4, 2026 AForm 4 → | Sep 8, 5:01 pm EDT | Faisal MehmudChief Medical Officer | 1,470,588 | $0.1705 | $250,735 | 1,470,588 | — | |
| Sep 4, 2026 AForm 4 → | Sep 8, 5:01 pm EDT | Edward J. BrennanChief Scientific Officer | 588,235 | $0.1705 | $100,294 | 674,735 | — | |
| Sep 4, 2026 AForm 4 → | Sep 8, 5:00 pm EDT | Carolyn F. BonnerPresident and CFO | 1,470,588 | $0.1705 | $250,735 | 1,489,493 | — | |
| Sep 4, 2026 AForm 4 → | Sep 8, 5:00 pm EDT | Raza BokhariChief Executive Officer, Director | 2,941,176 | $0.1705 | $501,471 | 2,941,176 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2026 AForm 4 → | Sep 8, 5:02 pm EDT | Andrew Alasdair SmithChief Operating Officer | 125,000 | — | — | 125,000 | — | |
| Sep 4, 2026 AForm 4 → | Sep 8, 5:01 pm EDT | Faisal MehmudChief Medical Officer | 250,000 | — | — | 250,000 | — | |
| Sep 4, 2026 AForm 4 → | Sep 8, 5:01 pm EDT | Edward J. BrennanChief Scientific Officer | 100,000 | — | — | 100,000 | — | |
| Sep 4, 2026 AForm 4 → | Sep 8, 5:00 pm EDT | Carolyn F. BonnerPresident and CFO | 250,000 | — | — | 250,000 | — | |
| Sep 4, 2026 AForm 4 → | Sep 8, 5:00 pm EDT | Raza BokhariChief Executive Officer, Director | 500,000 | — | — | 500,000 | — |